Clinical Trials Logo

Clinical Trial Summary

The recovery of walking ability is crucial to promote independence in daily living and is one of the major goal of neuromotor rehabilitation.

Currently, standard rehabilitative programs are usually based on straight-walking training (SWT) and the assessment of their effects is performed through functional scales based on straight-walking trajectories, e.g. Timed Up and Go (TUG), 10 meters walking test (10mWT).

Curved-walking training (CWT) may be interesting to provide an ecological and challenging context during rehabilitation. Indeed, CWT is based on demanding neural processes that drive an asymmetrical contribution at lower limb level, challenging balance ability and complex adaptation such as body weight shifting in response to centrifugal force and production of different step lengths.

Up to now, literature has investigated CWT in healthy adults in terms of muscular activation, kinematics and kinetics of the movement. Results showed that CWT needs a different biomechanical strategy with respect to SWT. Nevertheless CWT has not been investigated in pathological adults.

The present study aims at assessing the effectiveness of a rehabilitative physical therapy based on CWT with respect to traditional SWT for the recovery of locomotor abilities in neurological and orthopaedic patients.

The hypothesis is that a training based on curved-walking is ecologically meaningful and may be superior with respect to standard training in improving balance, walking abilities, and independence in activity of daily live of patients.

A secondary aim of the project is to propose an innovative functional scale based on the timed up and go on curved trajectory (CTUG), and to determine its reliability and responsiveness, establishing the minimum Detectable Change (MDC) and the Minimal Clinically Important Difference (MCID).

A single-blind randomized controlled study is being carried out on three different populations:

- Post-acute stroke patients

- Idiopathic Parkinson Disease

- Femoral fracture

A healthy group is also being recruited to provide reference values of CTUG. For each of the three populations, subjects are randomized into two groups. The experimental one performs a novel rehabilitative program composed by a 30-minute training on curved trajectory ("S" trajectory composed by two semicircle with a radius of 1.2 m) in addition to usual care. The control group performs an equal dose of traditional treatment on straight trajectories.

Both groups undergo 20 90-minutes sessions of training (three times a week for seven weeks).

Participants are evaluated at baseline (T0), after training (T1), and at a three-months follow-up visit (T2).

The primary outcome measure is the 10mWT (minimal clinically important difference of 0.16 m/s identified by Tilson and colleagues). On the basis of this measure, a sample size of 70 subjects for each population was computed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03545477
Study type Interventional
Source Istituti Clinici Scientifici Maugeri SpA
Contact Giorgio Ferriero
Phone 00390394657259
Email giorgio.ferriero@icsmaugeri.it
Status Recruiting
Phase N/A
Start date January 1, 2018
Completion date January 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Recruiting NCT03446833 - LFP Beta aDBS Feasibility Study N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Not yet recruiting NCT03618901 - Rock Steady Boxing vs. PD SAFEx N/A
Not yet recruiting NCT03664609 - Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Recruiting NCT03257046 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease Phase 1/Phase 2
Recruiting NCT03295786 - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease Phase 1/Phase 2
Completed NCT03103399 - Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon Phase 2
Recruiting NCT03104725 - Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease? N/A
Recruiting NCT03665454 - PF 06412562 in Subjects With Advanced Stage Parkinson's Disease Phase 1
Recruiting NCT03014050 - Bio Electro Stimulation Therapy for Parkinson's Disease N/A
Not yet recruiting NCT03582371 - Aqua Stand-Up Paddle Balance Effect in Parkinson's Disease (AquaSUP PARK) N/A
Not yet recruiting NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Not yet recruiting NCT03551392 - Pilot Intervention With Near Infrared Stimulation N/A
Not yet recruiting NCT03575195 - Microbiota Intervention to Change the Response of Parkinson's Disease Phase 1/Phase 2
Not yet recruiting NCT03648749 - Evaluation of a Speech-to-noise Feedback Device for Treatment of Hypophonia in Parkinson's Disease N/A
Recruiting NCT03045211 - Post-Physical Therapy Extension of In-Home Dynamic Standing Table Use in Parkinson Disease N/A
Recruiting NCT02601586 - Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease Phase 2/Phase 3
Recruiting NCT02823158 - Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM N/A
Recruiting NCT03192046 - Bracing for Walking in Parkinson's Disease N/A